Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 4 Schemes (3.34%)
Foreign Institutions
Held by 8 Foreign Institutions (0.88%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Mar 2022)
Net Profit:
-16 Million
Pharmaceuticals & Biotechnology
USD 0 Million ()
0
NA
0.00%
-0.81
-999,999.00%
0.00






